Sign up to our newsletter Subscribe
Challenges and Solutions for Budget Impact Analysis of Gene Therapies

This report provides a detailed summary of a panel session which took place at the HTAi 2016 annual meeting in Tokyo. The panel session was entitled “New Age Decision Making in HTA: Is It Applicable in Asia?”. To open the session, David Grainger…
This report provides a detailed summary of a panel session which took place at the HTAi 2016 annual meeting in Tokyo. The panel session was entitled “New Age Decision Making in HTA: Is It Applicable in Asia?”. To open the session, David Grainger (Eli Lilly & Company) provided an overview of the session, offering useful background information on the topic.
“New Age” Decision Making in HTA: Is It Applicable in Asia?